#25-05 Information regarding the last day of trading in paid subscribed units and the first day of trading in warrants issued by Northern CapSek Ventures AB
Reading Time: < 1 minute The unit issue in Northern CapSek Ventures AB (“The Company”) is now registered with the Swedish Companies Registration Office and the last day of trading in paid subscribed units has been set for January 14, 2025. The first day
THOMSON ADDS ENCODER OPTION TO STEPPER MOTOR LINEAR ACTUATOR ONLINE SELECTION TOOL
Reading Time: 3 minutes Editorial Contact: Priya Sharma – +44 (0) 203 965 7415Company Contact: Kevin Bastian – +1 630 694 3342 Please quote the following contact information when publishing:Tel.: 540.633.3549, Fax: 540.633.0294, www.thomsonlinear.com; Thomson@regalrexnord.com 01.08.2024, DOWNERS GROVE, IL – Thomson Industries, Inc., a
Symrise’s recommended offer to the shareholders of Probi expires soon; regulatory approval received
Reading Time: 6 minutes The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in, any jurisdiction in which the making of
ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 10.01.2025
Reading Time: < 1 minute ALEXANDRIA GROUP OYJ NOTIFICATION 10.01.2025 at 18:30 EET ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 10.01.2025 Date 10.01.2025 Exchange transaction Buy Share class ALEX Amount 10 Average price/share 8,7500 EUR Highest
FISKARS CORPORATION: ACQUISITION OF OWN SHARES 10.01.2025
Reading Time: < 1 minute Stock Exchange Release 10.01.2025 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 10.01.2025 Date 10.01.2025 Exchange transaction Buy Share class FSKRS Amount 2000 Average price/share 14.7915 EUR Highest price/share 14.8200 EUR Lowest price/share
Fitch Affirms Investment Grade Rating of ’BBB-’ for Heimstaden Bostad, Raised Outlook to Stable
Reading Time: < 1 minute Fitch affirms Heimstaden Bostad’s Long-Term Issuer Default rating (IDR) of ‘BBB-‘ and raises the Outlook to Stable from Negative. Co-CEO Christian Fladeland comments: “The stable outlook validates that Heimstaden Bostad continues to deliver on its base case performance which
Sobi’s full year 2024 revenue higher than previous estimate
Reading Time: 2 minutes Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) announces today that revenue for the full year 2024 was higher than previous estimate. Full-year revenue was approximately SEK 26,000 M, representing approximately 19% growth at constant exchange rate (CER) (1). Adjusted EBITA margin (1,2)
ABAX disputes Greater Than’s claims in its entirety
Reading Time: < 1 minute Read original Larvik (Norway), January 10, 2025 – In reference to the press release of January 10th issued by Greater Than, accusing ABAX of infringing upon contractually regulated intellectual property (IP) rights, ABAX categorically refutes these allegations. ABAX find it
2025 Roadmap: Boomerang Partners Targets Growth in iGaming
Reading Time: 2 minutes Boomerang Partners has shared its plans for 2025. This rapidly growing global company is preparing for new products and global expansion. After a successful 2024, it is ready to strengthen its position in iGaming with a key focus on sports betting. Boomerang
Invitation to monthly digital events and presentations of quarterly report
Reading Time: < 1 minute Hamlet BioPharma is pleased to announce the continuation of the digital event series in the spring of 2025. These events provide participants a valuable opportunity to follow and discuss our drug development process and engage directly with our team during